State of Wisconsin Investment Board’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.9M Sell
475,058
-23,646
-5% -$4.45M 0.18% 87
2026
Q1
$96.6M Buy
+498,704
New +$96.2M 0.22% 70
2024
Q3
– Sell
-151,160
Closed -$23.6M – 2292
2024
Q2
$23.6M Sell
151,160
-102,248
-40% -$15.4M 0.06% 282
2024
Q1
$34.3M Buy
253,408
+85,829
+51% +$11.4M 0.09% 199
2023
Q4
$22.6M Hold
167,579
– – 0.06% 288
2023
Q3
$22.7M Buy
+167,579
New +$22.9M 0.07% 263
2022
Q2
– Sell
-185,615
Closed -$24.6M – 2800
2022
Q1
$24.6M Sell
185,615
-122,695
-40% -$14.7M 0.05% 363
2021
Q4
$35.9M Buy
308,310
+76,748
+33% +$9.03M 0.07% 299
2021
Q3
$27.8M Sell
231,562
-162,513
-41% -$18.9M 0.06% 360
2021
Q2
$47.2M Buy
+394,075
New +$43.2M 0.1% 230
2014
Q3
– Sell
-10,000
Closed -$743K – 1332
2014
Q2
$743K Buy
+10,000
New +$723K ﹤0.01% 1303

Other funds holding AZN

State of Wisconsin Investment Board's AZN Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its AstraZeneca (AZN) stake by 4.7% in Q2 2026, selling an estimated $4.45M and leaving 475,058 shares worth $88.9M. The position accounts for 0.18% of the portfolio, ranked #87.

State of Wisconsin Investment Board first reported a position in AZN in Q2 2014 and has held it in 11 quarters since. The position peaked at $96.6M in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • State of Wisconsin Investment Board held 475,058 shares of AstraZeneca worth $88.9M as of Q2 2026.
  • State of Wisconsin Investment Board sold 23,646 AstraZeneca shares in Q2 2026, an estimated $4.45M.
  • AstraZeneca made up 0.18% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #87 holding.
  • State of Wisconsin Investment Board first reported a position in AstraZeneca in Q2 2014 and has held it in 11 quarters since.
  • State of Wisconsin Investment Board's AstraZeneca position peaked at $96.6M in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.